慢性腰痛の世界市場の機会と戦略（～2034年）

世界の慢性腰痛の市場規模は、2019年に67億9,252万米ドルであり、2024年まで2.00%を超えるCAGRで成長しました。

有利な政府の取り組み

有利な政府の取り組みは、過去の期間における慢性腰痛市場の成長を支えました。多くの国の政府は、医療インフラの改善、保険適用範囲の拡大、治療費の助成を目的とした政策を実施しており、慢性腰痛患者が治療を受けやすく、経済的な余裕を持てるようにしています。このような取り組みには、慢性疼痛に特化した疼痛管理プログラムやクリニックの開発が含まれることが多いです。例えば2021年8月、ドイツ政府はFPZ（Research and Prevention Center）Conceptを開発し、非常に効果的な治療プログラムとして、何十万人もの患者に腰痛の緩和を提供してきました。このアプローチは、包括的な評価と、背骨を安定させる筋肉を強化するために設計された個別のトレーニングレジメンを組み合わせたものです。治療は、生体力学的な問題を特定する初期評価、筋力と柔軟性に焦点を当てたカスタマイズされたトレーニングプログラム、再発防止に向けた継続的なメンテナンスの3段階からなります。調査によると、患者の約93.5%が疼痛を緩和でき、多くの患者が完全な回復と、筋力と可動性の大幅な改善を報告しています。そのため、有利な政府の取り組みが慢性腰痛市場の成長を後押ししました。

当レポートでは、世界の慢性腰痛市場について調査分析し、市場の特徴、主な市場動向、市場規模と成長の予測、競合情勢などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

• 慢性腰痛 - 市場の魅力とマクロ経済情勢

第2章 目次

第3章 表のリスト

第4章 図表のリスト

第5章 レポートの構成

第6章 市場の特徴

• 一般的な市場の定義
• サマリー
• 慢性腰痛市場の定義とセグメンテーション
• 市場のセグメンテーション：疼痛タイプ別
  • 椎間板性疼痛
  • 腰部脊椎管狭窄症
  • 仙腸関節痛
  • 椎間関節痛
  • 神経根痛
  • 筋肉痛
  • その他の疼痛タイプ
• 市場のセグメンテーション：診断別
  • 病歴
  • 身体検査
  • イメージングガイドライン
  • 疼痛の評価
• 市場のセグメンテーション：エンドユーザー別
  • 病院
  • 整形外科クリニック
  • 外来手術センター
  • その他のエンドユーザー

第7章 主な市場動向

• 非外科的腰痛と脚痛の治療向けに承認された革新的な脊髄刺激法
• AIを活用した脊髄刺激が疼痛治療を再定義する
• 脊髄刺激技術による慢性腰痛治療の革命
• AIと医学的知見を活用した、腰痛に対する個別化されたソリューション
• さまざまな原因による慢性疼痛を管理する先進の治療施設
• 最先端のTGF-B調節療法が臨床試験で進歩する

第8章 慢性腰痛市場 - マクロ経済シナリオ

• 慢性腰痛市場に対するCOVID-19の影響
• 慢性腰痛市場に対するウクライナ戦争の影響
• 慢性腰痛市場に対する高インフレの影響

第9章 世界の市場規模と成長

• 市場規模
• 市場成長の実績（2019年～2024年）
  • 市場促進要因（2019年～2024年）
  • 市場抑制要因（2019年～2024年）
• 市場成長の予測（2024年～2029年・2034年）
  • 市場促進要因（2024年～2029年）
  • 市場抑制要因（2024年～2029年）

第10章 世界の慢性腰痛市場のセグメンテーション

• 世界の慢性腰痛市場：疼痛タイプ別、実績と予測（2019年～2024年・2029年・2034年）
• 世界の慢性腰痛市場：診断別、実績と予測（2019年～2024年・2029年・2034年）
• 世界の慢性腰痛市場：エンドユーザー別、実績と予測（2019年～2024年・2029年・2034年）

第11章 慢性腰痛市場、地域と国の分析

• 世界の慢性腰痛市場：地域別、実績と予測（2019年～2024年・2029年・2034年）
• 世界の慢性腰痛市場：国別、実績と予測（2019年～2024年・2029年・2034年）

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

• 企業プロファイル
• Johnson & Johnson
• Pfizer Inc
• Novartis AG
• Medtronic Inc
• Eli Lilly and Company

第20章 その他の主要企業と革新的企業

• Hisamitsu Pharmaceutical Co. Inc
• Boehringer Ingelheim GmbH
• AstraZeneca plc
• Endo International plc
• AbbVie Inc
• Grunenthal GmbH
• Amgen Inc
• Teva Pharmaceutical Industries Ltd
• Collegium Pharmaceutical Inc
• Merck & Co. Inc
• BioWave Corporation
• Boston Scientific Corporation
• Abbott Laboratories
• Vertebral Technologies Inc
• Neuraxpharm Group

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主な合併と買収

• Boston Scientific Acquired Relievant Medsystems To Expand Chronic Pain Management Portfolio
• Stryker Corporation Acquired Vertos Medical To Enhance Minimally Invasive Pain Management Portfolio
• Nevro Corp Acquired Vyrsa Technologies For Expanding Chronic Pain Treatment Solutions
• Silony Medical International AG Acquired Centinel Fusion Portfolio To Improve Treatment Options

第24章 機会と戦略

• 世界の慢性腰痛市場 - もっとも新しい機会を提供する国（2029年）
• 世界の慢性腰痛市場 - もっとも新しい機会を提供するセグメント（2029年）
• 世界の慢性腰痛市場 - 成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競合の戦略

第25章 慢性腰痛市場：結論と提言

• 結論
• 提言
  • 製品
  • 流通
  • 価格
  • プロモーション
  • 人々

第26章 付録

The chronic lower back pain market consists of sales, by entities (organizations, sole traders and partnerships) that arise from a variety of underlying causes, including structural, neurological and muscular issues and its management requires tailored approaches depending on the pain type and severity. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression and/or anxiety.

Patients experiencing chronic lower back pain may seek medical attention from healthcare providers such as general practitioners, orthopedic specialists, neurologists and physiotherapists. The condition is commonly managed through diagnostic and treatment pathways involving clinical evaluations, imaging studies and interventional or non-interventional therapies. Treatment options range from pharmacological approaches, such as analgesics and anti-inflammatory drugs, to physical therapy, surgical interventions and alternative methods such as acupuncture or chiropractic care. The management of CLBP is often multidisciplinary, involving collaboration between specialists and support teams to ensure optimal outcomes.

The global chronic lower back pain market was valued at $6,792.52 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 2.00%.

Favorable Government Initiatives

The favorable government initiatives supported the growth of the chronic lower back pain market in the historic period. Governments in many countries have implemented policies aimed at improving healthcare infrastructure, increasing insurance coverage and subsidizing treatments, making it easier for individuals with chronic lower back pain to seek and afford care. These initiatives often include the development of specialized pain management programs and clinics, which provide focused attention on chronic pain conditions. For example, in August 2021, government of Germany developed the FPZ (Research and Prevention Center) Concept is a highly effective treatment program, that has provided back pain relief to hundreds of thousands of patients. This approach combines comprehensive assessments with individualized training regimens designed to strengthen the spine's stabilizing musculature. The treatment consists of three phases: an initial assessment to identify biomechanical issues, a customized training program focusing on strength and flexibility and ongoing maintenance to prevent recurrence. Research shows that approximately 93.5% of patients experience pain relief, with many reporting complete recovery, alongside significant improvements in strength and mobility. Therefore, favorable government initiatives drove the growth of the chronic lower back pain market.

AI-Infused Spinal Cord Stimulation Redefines Pain Therapy

Companies operating in the chronic lower back pain market are focusing on artificial intelligence (AI)- infused spinal cord stimulation redefines pain therapy. This technology improves the accuracy and efficacy of treatment but also reduces the need for manual adjustments by healthcare providers, leading to better patient outcomes. For instance, in September 2024, Nevro, a US-based medical device company, launched HFX AdaptivAI (High-Frequency Stimulation Adaptive Artificial Intelligence), an innovative spinal cord stimulation technology that incorporates artificial intelligence to enhance pain management for chronic pain sufferers. This technology is positioned as a unique solution within the spinal cord stimulation market, promising improved patient outcomes through adaptive therapy. HFX AdaptivAI delivers personalized pain relief, utilizing AI and leveraging millions of data points and ten years of innovation and patient care.

The global chronic lower back pain market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 42.25% of the total market in 2023.

Chronic Lower Back Pain Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global chronic lower back pain market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for chronic lower back pain? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The chronic lower back pain market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider chronic lower back pain market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of pain, by diagnosis and by end-user.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the chronic lower back pain market.
• Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of pain, by diagnosis and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for chronic lower back pain providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
• 2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain
• 3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users
• Companies Mentioned: Johnson & Johnson Services Inc.; Pfizer Inc.; Novartis AG; Medtronic plc; Eli Lilly and Company; Hisamitsu Pharmaceutical Co. Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chronic lower back pain indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Chronic Lower Back Pain - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Chronic Lower Back Pain Market Definition And Segmentations
• 6.4 Market Segmentation By Type Of Pain
  • 6.4.1 Diskogenic Pain
  • 6.4.2 Lumbar Spinal Stenosis
  • 6.4.3 Sacroiliac Pain
  • 6.4.4 Facet-Joint Pain
  • 6.4.5 Radicular Pain
  • 6.4.6 Muscular Pain
  • 6.4.7 Other Types Of Pain
• 6.5 Market Segmentation By Diagnosis
  • 6.5.1 Clinical History
  • 6.5.2 Physical Examination
  • 6.5.3 Imaging Guidelines
  • 6.5.4 Assessment Of Pain
• 6.6 Market Segmentation By End-User
  • 6.6.1 Hospitals
  • 6.6.2 Orthopedic Clinics
  • 6.6.3 Ambulatory Surgery Centers
  • 6.6.4 Other End-Users

7 Major Market Trends

• 7.1 Innovative Spinal Cord Stimulation Approved For Non-Surgical Back And Leg Pain
• 7.2 AI-Infused Spinal Cord Stimulation Redefines Pain Therapy
• 7.3 Revolutionizing Chronic Back Pain Treatment With Spinal Cord Stimulation Technology
• 7.4 Personalized Back Pain Solutions Powered By AI And Medical Insights
• 7.5 Advanced Treatment Facility For Managing Chronic Pain From Various Causes
• 7.6 Cutting-Edge TGF-B Modulation Therapy Progresses In Clinical Trials

8 Chronic Lower Back Pain Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Chronic Lower Back Pain Market
• 8.2 Impact Of The War In Ukraine On The Chronic Lower Back Pain Market
• 8.3 Impact Of High Inflation On The Chronic Lower Back Pain Market

9 Global Market Size Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 9.2.1 Market Drivers 2019 - 2024
  • 9.2.2 Market Restraints 2019 - 2024
• 9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 9.3.1 Market Drivers 2024 - 2029
  • 9.3.2 Market Restraints 2024 - 2029

10 Global Chronic Lower Back Pain Market Segmentation

• 10.1 Global Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.3 Global Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Chronic Lower Back Pain Market, Regional and Country Analysis

• 11.1 Global Chronic Lower Back Pain Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.2 Global Chronic Lower Back Pain Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.3 Asia-Pacific Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Asia-Pacific Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Asia-Pacific Chronic Lower Back Pain Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 China Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 China Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 India Market
• 12.12 India Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 India Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 India Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 Japan Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 Japan Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Australia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Australia Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Indonesia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Indonesia Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.29 South Korea Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.30 South Korea Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate tax structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.3 Western Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Western Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Western Europe Chronic Lower Back Pain Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 UK Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 UK Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.12 Germany Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.13 Germany Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.14 France Market
• 13.15 France Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.16 France Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.17 France Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.20 Italy Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.21 Italy Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.24 Spain Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.25 Spain Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Major Companies
• 14.2 Eastern Europe Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.3 Eastern Europe Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 Eastern Europe Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 Eastern Europe Chronic Lower Back Pain Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.8 Russia Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.9 Russia Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.3 North America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 North America Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 North America Chronic Lower Back Pain Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 USA Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.10 USA Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.13 Canada Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.14 Canada Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Major Companies
• 16.2 South America Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.3 South America Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 South America Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Brazil Market
• 16.6 Brazil Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.7 Brazil Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.8 Brazil Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.3 Middle East Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Middle East Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Chronic Lower Back Pain Market, Segmentation By Type Of Pain, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 18.3 Africa Chronic Lower Back Pain Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 18.4 Africa Chronic Lower Back Pain Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Johnson & Johnson
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Pfizer Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Novartis AG
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Medtronic Inc
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Eli Lilly and Company
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Hisamitsu Pharmaceutical Co. Inc
  • 20.1.1 Company Overview
  • 20.1.2 Products and Services
• 20.2 Boehringer Ingelheim GmbH
  • 20.2.1 Company Overview
  • 20.2.2 Products and Services
• 20.3 AstraZeneca plc
  • 20.3.1 Company Overview
  • 20.3.2 Products and Services
• 20.4 Endo International plc
  • 20.4.1 Company Overview
  • 20.4.2 Products and Services
• 20.5 AbbVie Inc
  • 20.5.1 Company Overview
  • 20.5.2 Products and Services
• 20.6 Grunenthal GmbH
  • 20.6.1 Company Overview
  • 20.6.2 Products and Services
• 20.7 Amgen Inc
  • 20.7.1 Company Overview
  • 20.7.2 Products and Services
• 20.8 Teva Pharmaceutical Industries Ltd
  • 20.8.1 Company Overview
  • 20.8.2 Products and Services
• 20.9 Collegium Pharmaceutical Inc
  • 20.9.1 Company Overview
  • 20.9.2 Products and Services
• 20.10 Merck & Co. Inc
  • 20.10.1 Company Overview
  • 20.10.2 Products and Services
• 20.11 BioWave Corporation
  • 20.11.1 Company Overview
  • 20.11.2 Products and Services
• 20.12 Boston Scientific Corporation
  • 20.12.1 Company Overview
  • 20.12.2 Products and Services
• 20.13 Abbott Laboratories
  • 20.13.1 Company Overview
  • 20.13.2 Products and Services
• 20.14 Vertebral Technologies Inc
  • 20.14.1 Company Overview
  • 20.14.2 Products and Services
• 20.15 Neuraxpharm Group
  • 20.15.1 Company Overview
  • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Boston Scientific Acquired Relievant Medsystems To Expand Chronic Pain Management Portfolio
• 23.2 Stryker Corporation Acquired Vertos Medical To Enhance Minimally Invasive Pain Management Portfolio
• 23.3 Nevro Corp Acquired Vyrsa Technologies For Expanding Chronic Pain Treatment Solutions
• 23.4 Silony Medical International AG Acquired Centinel Fusion Portfolio To Improve Treatment Options

24 Opportunities And Strategies

• 24.1 Global Chronic Lower Back Pain Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global Chronic Lower Back Pain Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global Chronic Lower Back Pain Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Chronic Lower Back Pain Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer